Nuvectis Pharma prices $100 million public offering at $20/share
AI Summary
Nuvectis Pharma completed a public offering of $100 million, pricing shares at $20 each. This financial move aims to strengthen the company's capital base.
Related Articles
The AI jobs debate just got messier
TechCrunch —
Sea-Intelligence: Global Schedule Reliability for May 2026 the Highest of the Year
Container News —
Litchfield eyes fresh NT targets after BHP Xplor model review
The Sydney Morning Herald —
[Vantage Point] CBK: The battle for Luzonβs battery
Rappler —
ααΆαααααααααααααΈαααα»αα±ααααααα»ααΆα αΆαα ααααΈαααα»αααααααα’αα·αααααααα·α αα½α αα ααααΆαα’α α’α© ααααααααΆααααΆ αααααααα·αα’αΆα ααΉαααα’ααααΎαααα½ααααααααΆααααα αΌαααΆααα
Khmer Times —
Sempra's Port Arthur Connector Completes A Critical Link In U.S. LNG Export Infrastructure
Seeking Alpha —